Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

dc.contributor.author	Baji, Petra
dc.contributor.author	Gulácsi, László
dc.contributor.author	Brodszky, Valentin
dc.contributor.author	Végh, Zsuzsanna
dc.contributor.author	Danese, S
dc.contributor.author	Irving, PM
dc.contributor.author	Peyrin, Biroulet L
dc.contributor.author	Schreiber, S
dc.contributor.author	Rencz, Fanni
dc.contributor.author	Lakatos, Péter László
dc.contributor.author	Péntek, Márta
dc.date.accessioned	2020-04-24T06:53:30Z
dc.date.available	2020-04-24T06:53:30Z
dc.date.issued	2018
dc.identifier.citation	journalVolume=6;journalIssueNumber=2;journalTitle=UNITED EUROPEAN GASTROENTEROLOGY JOURNAL;pagerange=310-321;journalAbbreviatedTitle=UEG JOURNAL;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/7180
dc.identifier.uri	doi:10.1177/2050640617708952
dc.description.abstract	Background: In clinical practice, treatment sequences of biologicals are applied for active fistulising Crohn's disease, however underlying health economic analyses are lacking.
dc.format.extent	310-321
dc.relation.ispartof	urn:issn:2050-6406 2050-6414
dc.title	Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe
dc.type	Journal Article
dc.date.updated	2019-07-07T11:08:24Z
dc.language.rfc3066	en
dc.identifier.mtmt	3227078
dc.identifier.wos	000429973300015
dc.identifier.scopus	85042535167
dc.identifier.pubmed	29511561
dc.contributor.department	SE/AOK/K/I. Sz. Belgyógyászati Klinika
dc.contributor.institution	Semmelweis Egyetem
dc.mtmt.swordnote	Megjegyzés-27582082 Megjegyzés-27680096